Innervace
PrivateLast Round
Series A
Sep 8, 2022
Total Funding Raised
$41.1M
Company Overview
Innervace is a biotechnology company that develops implantable tissue-engineered brain pathways for the treatment of neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innervace Comparables
Compare Innervace with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kenai Therapeutics | 84% | |
| Oryon Cell Therapies | 81% | |
| BE Therapeutics | 81% | |
Innervace Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 8, 2022 |
Innervace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A |
| IP Group | Series A |
| WARF Ventures | Series A |
| Bio-Reference Laboratories, Inc. | Series A |
| WARF | Series A |
| Anzu Partners | Series A |
| Longview Innovation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 8, 2022
$40M round led by Deerfield Management
Innervace Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innervace's valuation, stock price, and market status.